Comparison Immune Response in Paravertebral and Erector Spinal Plane Block in Breast Cancer Patients

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-70
SponsorClinical Hospital Center Rijeka

About this trial

The goal of this clinical trial is to find the difference in immune response between two types of regional anesthesia in female patients suffering from breast cancer.

The main question it aims to answer is there a difference in the immune response between paravertebral block and erector spinal plane block.

Hypothresis of the study is that paravertebral block with propofol induces less immune response in surgical treatment of breast cancer patients than erector spinal plane block.

Participants will be asked to sign the informant consent. They will be given either paravertebral block or erector spinae plane block with general anesthesia using propofol. Their venous blood will be taken 1 hour prior surgery and 24 and 48 hours after surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

ASA I and ASA II status, normal BMI

Disqualifiers

ASA III and ASA IV status, coagulopathy, chronic opioid use, diabetes, local infection of the skin

Trial design

Design model

Parallel

Treatments tested in this trial

  • Regional Anesthetic Injection

    Procedure/Surgery

    Draw of venous blood and application of paravertebral and erector spinae plane block

  • Blood draw for the laboratory assessment

    Procedure/Surgery

    Draw of venous blood 24 hours after surgery

  • Blood draw for the laboratory assessment

    Procedure/Surgery

    Blood draw 48 hours after surgery

Treatment groups

56 Participants
are divided into 3 treatment groups
Group A: Draw of venous blood 1 hour prior surgeryExperimental treatment 1 intervention
Group B: Draw of venous blood 24 hours after surgeryExperimental treatment 1 intervention
Group C: Draw of venous blood 48 hours after surgeryExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Immune response in two different regional anesthesia techniques

Time frame
From enrollment to 30 days post surgery

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: